Top Markets
Coin of the day
CRISM Therapeutics Corporation CRISM Therapeutics Corporation

CRISM Therapeutics Corporation

CRTX
Classifica tra le azioni #40980
CRISM Therapeutics Corporation is dedicated to developing innovative drug... CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.
Prezzo delle azioni
$0.14355401
Capitalizzazione di mercato
$55.27K
Variazione (1 giorno)
-1.86%
Variazione (1 anno)
1.06%
Paese
VG
Scambia CRISM Therapeutics Corporation (CRTX)

Categoria

Storico del rendimento da dividendi per CRISM Therapeutics Corporation (CRTX)
Il rendimento da dividendi (TTM) di CRISM Therapeutics Corporation (simbolo azionario: CRTX) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per CRISM Therapeutics Corporation (CRTX) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
0.65%
BE